Skip to main content
Support
Article

US-China Race in Precision Medicine - A Map of Genomics Companies

US-China Race in Precision Medicine - A Map of Genomics Companies

With powerful backers, iCarbonX is the most emblematic start-up, but not only one at the convergence of AI and genomics: an ever expanding network of IT and bio-computing companies is rapidly conquering the Chinese and U.S. health markets. The Consultant firm Frost & Sullivan predicts AI system will generate 6.7 billion in global revenue from health care by 2021, compared with $633.8 million in 2014. AI systems are quickly invading the lab and the clinic to make sense of the increasing trove of genomic data - by 2025, between 100 million and 2 billion human genomes could be sequenced - an effort that will exceed the computing challenges of running YouTube and Twitter.

This below map shows respective - US and China - capacities in genomics and AI and their related investments and partnerships.

Contributor

Eleonore Pauwels

Eleonore Pauwels

Former Global Fellow;
Formerly European Commission, Directorate-General for Research and Technological Development, Directorate on Science, Economy and Society
Read More

Science and Technology Innovation Program

The Science and Technology Innovation Program (STIP) serves as the bridge between technologists, policymakers, industry, and global stakeholders.  Read more